Abstract
Metabotropic glutamate receptors (mGluRs) are G-protein coupled receptors (GPCRs) activated by glutamate. The function of mGluRs is not restricted to the regulation of synaptic transmission. Although some roles of mGluR5 in mouse embryonic stem cells (ESCs) have been proposed, little is known about the significance of mGluR5 in cardiomyocyte differentiation from ESCs. We demonstrated that mGluR5 expression increased during cardiomyocyte differentiation. Activation of mGluR5 with (RS)-3, 5-dihydroxy phenylglycine (DHPG) promoted cardiomyocyte differentiation in a dose-dependent manner. DHPG significantly enhanced PI 3-kinase enhancer (PIKE) and PI3K p110α expression, but had no significant effect on Homer1b/c. The coexpression of PIKE or PI3K p110α together with Troponin T in embryoid bodies (EBs) treated with DHPG was elevated to 9.51% and 12.05%, respectively. Inhibition of mGluR5 with 2-methyl-6-(phenylethynyl)pyridine (MPEP) treating the ESCs, did hold back the cardiogenesis from the ESCs at the early differentiation stage. However, EBs applied by MPEP could not inhibit cardiomyocyte differentiation. Small interfering RNA (siRNA) of mGluR5 blocked cardiomyocyte differentiation by repressing PIKE and PI3K p110α expression, but had no notable influence on Homer1b/c. mGluR5 siRNA also decreased the DHPG-induced Ca2+ transient peak amplitude in the isolated ESC-derived cardiomyocytes. The amplitude of Ca2+ oscillation was reduced by ∼90% with si-mGluR5-3 compared with si-control. The protein expression of T-type Ca2+ channel and L-type Ca2+ channel was decreased in si-mGluR5-3–treated EBs. Taken together, these results revealed that mGluR5/PIKE/PI3K signaling pathway was involved in cardiomyocyte differentiation from ESCs. The key function of mGluR5 is probably associated with cardiogenesis and Ca2+ signal in ESC-derived cardiomyocytes.
Get full access to this article
View all access options for this article.